webinar register page

Webinar banner
Specialty CME Series: COVID-19 and Hematologic Disturbances
The Specialty CME Series is designed to provide oncologists, primary care providers or other specialists with the latest information, data, best practices, recommendations and guidelines for treating cancer patients.

In this episode of the series, Syed A. Abutalib, MD, will discuss the management of patients with COVID-19 infections and hematologic disturbances.

After participating in this education, learners will be able to:
Discuss the management of patients with COVID-19 and hematologic malignancies

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Morehouse School of Medicine and Cancer Treatment Centers of America®. The Morehouse School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Morehouse School of Medicine designates this live activity for AMA PRA Category 1 CreditsTM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Feb 10, 2021 05:00 PM in Central Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Syed A. Abutalib, MD
Associate Medical Director, Hematologic Malignancies and Stem Cell Transplant Program - Chicago @Cancer Treatment Centers of America
Dr. Abutalib earned a medical degree from Dow Medical College in Karachi, Pakistan. He completed an internal medicine residency with an emphasis in hematologic malignancies at Cook County Hospital in Chicago. He completed a fellowship in hematology/oncology at the University of Illinois at Chicago (UIC), with an emphasis on blood and bone marrow transplantation. Dr. Abutalib has co-edited many hematology and bone marrow transplant books and has been published in a number of medical journals and textbooks. Dr. Abutalib is the associate editor for the American Society of Clinical Oncology (ASCO) magazine, The ASCO Post. He is also the reviewer for the journal Blood Reviews and the update editor for one of the leading textbooks, Hematology, Basic Principles and Practice (7th edition) by Hoffman. Additionally, he has presented at clinical conferences and meetings on a variety of topics related to hematologic disease, including the Chicago Lymphoma Society. Dr. Abutalib is board-certified.